Press Release For The Medicinal Product For Human Use «Pradaxa»

Original Language Title: Comunicato relativo al medicinale per uso umano «Pradaxa»

Read the untranslated law here:

Specialty PRADAXA.
Please be informed that the Committee, at its meeting on 26-27 prices and Reimbursement November 2014 expressed a favourable opinion on the new listings, without changing the price and negotiating conditions currently in force for the new indication below: for the dosages from 110 mg hard capsules and 150 mg capsules.
Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and prevention of recurrence of DVT and PE in adults.